Individualized breast cancer therapy using Mcl-1 inhibition based combination
© European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Breast cancer (BC) is leading cause of cancer-related mortality in wo...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 December 2016
|
| In: |
Annals of oncology
Year: 2016, Volume: 27 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/S0923-7534(21)00174-5 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S0923-7534(21)00174-5 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421001745 
|
| Author Notes: | M.H. Bashari, S. Malvestiti, F. Fan, S. Vallet, M.H. Cardone, J.T. Opferman, D. Jäger, K. Podar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1563389452 | ||
| 003 | DE-627 | ||
| 005 | 20240927095913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170911s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0923-7534(21)00174-5 |2 doi | |
| 035 | |a (DE-627)1563389452 | ||
| 035 | |a (DE-576)493389458 | ||
| 035 | |a (DE-599)BSZ493389458 | ||
| 035 | |a (OCoLC)1340979258 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bashari, Muhammad Hasan |d 1982- |e VerfasserIn |0 (DE-588)1058671995 |0 (DE-627)797396306 |0 (DE-576)414826507 |4 aut | |
| 245 | 1 | 0 | |a Individualized breast cancer therapy using Mcl-1 inhibition based combination |c M.H. Bashari, S. Malvestiti, F. Fan, S. Vallet, M.H. Cardone, J.T. Opferman, D. Jäger, K. Podar |
| 264 | 1 | |c 20 December 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.09.2017 | ||
| 520 | |a © European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Breast cancer (BC) is leading cause of cancer-related mortality in women. Anti-apoptotic Bcl-2 family members including Bcl-2, Bcl-xL and myeloid cell leukemia-1 (Mcl-1) control the intrinsic pathway of apoptosis. Elevated Mcl-1 levels have been correlated with poor prognosis. The aim of this study is to evaluate a rationally-derived combination of Mcl-1-inhibitor with Bcl-2 or Bcl-xL inhibitors as well as with conventional BC treatment and to provide the derived rationale to therapeutically target Mcl-1.Methods: The anti-BC cell-activity of the novel small molecule Mcl-1 inhibitor EU5346 was evaluated alone or in combination with other antiapoptotic agents, hormone therapy, targeted therapy, or chemotherapy using proliferation and spheroid forming assays as well as immunoblotting in different BC cell lines. Synergistic activity of combination... | ||
| 700 | 1 | |a Malvestiti, Stefano |e VerfasserIn |0 (DE-588)1139673270 |0 (DE-627)897410084 |0 (DE-576)493389431 |4 aut | |
| 700 | 1 | |a Fan, Fengjuan |e VerfasserIn |0 (DE-588)1058671855 |0 (DE-627)797396179 |0 (DE-576)414826426 |4 aut | |
| 700 | 1 | |a Vallet, Sonia |d 1976- |e VerfasserIn |0 (DE-588)105867207X |0 (DE-627)797396403 |0 (DE-576)414826493 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Podar, Klaus |e VerfasserIn |0 (DE-588)1058672169 |0 (DE-627)797396594 |0 (DE-576)414826795 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 27(2016, Supplement 9) Artikel-Nummer 12P, 1 Seite |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Individualized breast cancer therapy using Mcl-1 inhibition based combination |
| 773 | 1 | 8 | |g volume:27 |g year:2016 |g supplement:suppl_9 |a Individualized breast cancer therapy using Mcl-1 inhibition based combination |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0923-7534(21)00174-5 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753421001745 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170911 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1058672169 |a Podar, Klaus |m 1058672169:Podar, Klaus |d 910000 |d 910100 |e 910000PP1058672169 |e 910100PP1058672169 |k 0/910000/ |k 1/910000/910100/ |p 8 |y j | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 7 | ||
| 998 | |g 105867207X |a Vallet, Sonia |m 105867207X:Vallet, Sonia |d 910000 |d 910100 |e 910000PV105867207X |e 910100PV105867207X |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1058671855 |a Fan, Fengjuan |m 1058671855:Fan, Fengjuan |d 910000 |d 910100 |e 910000PF1058671855 |e 910100PF1058671855 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1139673270 |a Malvestiti, Stefano |m 1139673270:Malvestiti, Stefano |d 910000 |e 910000PM1139673270 |k 0/910000/ |p 2 | ||
| 998 | |g 1058671995 |a Bashari, Muhammad Hasan |m 1058671995:Bashari, Muhammad Hasan |d 910000 |d 910100 |e 910000PB1058671995 |e 910100PB1058671995 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1563389452 |e 2980008559 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Muhammad Hasan","display":"Bashari, Muhammad Hasan","family":"Bashari"},{"display":"Malvestiti, Stefano","family":"Malvestiti","role":"aut","given":"Stefano"},{"role":"aut","given":"Fengjuan","family":"Fan","display":"Fan, Fengjuan"},{"role":"aut","given":"Sonia","display":"Vallet, Sonia","family":"Vallet"},{"family":"Jäger","display":"Jäger, Dirk","role":"aut","given":"Dirk"},{"role":"aut","given":"Klaus","family":"Podar","display":"Podar, Klaus"}],"title":[{"title":"Individualized breast cancer therapy using Mcl-1 inhibition based combination","title_sort":"Individualized breast cancer therapy using Mcl-1 inhibition based combination"}],"origin":[{"dateIssuedDisp":"20 December 2016","dateIssuedKey":"2016"}],"note":["Gesehen am 11.09.2017"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1563389452","relHost":[{"disp":"Individualized breast cancer therapy using Mcl-1 inhibition based combinationAnnals of oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"recId":"320428796","physDesc":[{"extent":"Online-Ressource"}],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"part":{"volume":"27","text":"27(2016, Supplement 9) Artikel-Nummer 12P, 1 Seite","year":"2016"},"language":["eng"]}],"language":["eng"],"name":{"displayForm":["M.H. Bashari, S. Malvestiti, F. Fan, S. Vallet, M.H. Cardone, J.T. Opferman, D. Jäger, K. Podar"]},"id":{"eki":["1563389452"],"doi":["10.1016/S0923-7534(21)00174-5"]}} | ||
| SRT | |a BASHARIMUHINDIVIDUAL2020 | ||